Canopy Growth (TSX:WEED): When Will Its Stock Hit $75 Again?

Here is what can fuel more gains in Canopy Growth Corp. (TSX:WEED)(NYSE:CGC) stock.

| More on:

After surging more than 70% this year alone, Canopy Growth Corp. (TSX:WEED)(NYSE:CGC) stock looks expensive to some analysts and hedge fund managers. They argue that after the major deal activity during the past 12 months, there isn’t much left to look forward to and the company’s stock will struggle to reach new highs.

In the latest bull-run that started after April 15, the stock of the world’s most valuable pot company surged 15% as Canopy announced to acquire New York-based Acreage Holdings Inc. in its first cross-border deal.

The $3.4-billion takeover of Acreage, which has yet to go through a shareholder approval, is one of the biggest catalysts for the company this year, as the deal will bring one of the largest U.S.-based pot firms under its umbrella.

Acreage has cultivation, processing, and dispensing licences or agreements with holders in 19 states in the U.S. It also manages a chain of retail stores called The Botanist. As part of its plan to build an extraction and manufacturing facility in the U.S., a much bigger market for both medical and recreational marijuana, Canopy also acquired a hemp licence in New York State early this year.

What can fuel more gains in Canopy stock?

Besides these headline-grabbing deals, there are many other factors that could fuel further growth in Canopy stock. In my view, Canopy Growth stock still has more room to run. The biggest reason that makes me bullish on Canopy stock is the company’s early success in executing its marketing strategy after the October legalization of recreational marijuana use in Canada.

Canopy’s second-quarter earnings report, released in February, showed that the producer has begun to capture that major share in Canada’s pot market. During that period, its sales rose to $83 million, up 282% from a year earlier and ahead of the consensus estimate of $78.7 million.

No doubt, Canopy reported the lower-than-expected gross margin and its loss widened due to escalating costs, but what is reassuring for investors in these numbers is that Canopy is succeeding to maintain its leading market position in the fiercely competitive market.  

Eight Capital analyst Graeme Kreindler estimates that Canopy captured 40% of the Canadian recreational market since it opened up for recreational use, while BMO analyst Tamy Chen estimates that it captured 30% of the market.

Bottom line

Even after a very powerful rally in 2019, Canopy Growth stock is still trading about 19% lower than its all-time high it hit in October. I feel the stock can easily reach that level if Acreage shareholders approve the Canopy takeover and the producer continues to show strong growth in sales.

Fool contributor has no position in the stocks mentioned in this article.

More on Cannabis Stocks

four people hold happy emoji masks
Dividend Stocks

Wary of Mining Companies? A Lower-Risk Way to Get in on the Gold and Silver Surge

Frenco-Nevada (TSX:FNV) stock might be a wiser way to play the run in gold prices this year.

Read more »

Cannabis smoke
Cannabis Stocks

Have Cannabis Stocks Totally Gone Up in Smoke?

Let's dive into whether Canadian cannabis stocks are still investable, and what investors should make of the recent volatility in…

Read more »

Researcher works in hemp field
Cannabis Stocks

1 Undervalued Cannabis Stock to Buy and Hold Over the Next Decade

Green Thumb is a beaten-down cannabis stock that trades at a compelling valuation in September 2025.

Read more »

Researcher works in hemp field
Cannabis Stocks

Pot Stocks Rallied Hard in August: Is There More to Come?

Tilray Brands (TSX:TLRY) and the broad basket of pot stocks could heat up from here.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Canopy Growth Stock Jumped 30% Last Month: What’s Going on?

Canopy Growth (TSX:WEED) stock is picking up traction again, making it an enticing weed play to buy on strength.

Read more »

A cannabis plant grows.
Cannabis Stocks

These Threats Facing Canopy Growth Stock Could Justify Selling it

Let's dive into whether Canopy Growth (TSX:WEED) is a top stock investors should buy right now after its recent dip…

Read more »

A person holds a small glass jar of marijuana.
Stocks for Beginners

This BioCannabis Firm Could Explode with Product Approval

This cannabis stock used to be a major name, so where does it stand now?

Read more »

Medicinal research is conducted on cannabis.
Stocks for Beginners

This TSX Health-Care Stock Is a Long-Term Buy for Patient Investors

This TSX stock continues to be one of the best long-term opportunities, if you're patient.

Read more »